setogepram , G-protein coupled receptor 84 antagonist, CAS No.1002101-19-0, G-protein coupled receptor 84 antagonist

Item Number
S613548
Grouped product items
SKUSizeAvailabilityPrice Qty
S613548-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
S613548-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,001.90

Basic Description

Synonyms2-(3-Pentylphenyl)acetic acid | 1002101-19-0 (free acid) | BDBM50548388 | setogepram | DB15447 | HY-100775A | CS-0062694 | 1002101-19-0 | AKOS028113459 | Benzeneacetic acid, 3-pentyl- | Z1508932704 | EN300-1168886 | CQB10119 | 2-(3-Pentylphenyl)aceticacid
Specifications & PurityMoligand™
GradeMoligand™
Action TypeAGONIST, ANTAGONIST
Mechanism of actionG-protein coupled receptor 84 antagonist

Product Properties

ALogP4

Associated Targets(Human)

GPR84 Tchem G-protein coupled receptor 84 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FFAR1 Tchem Free fatty acid receptor 1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 2-(3-pentylphenyl)acetic acid
INCHI InChI=1S/C13H18O2/c1-2-3-4-6-11-7-5-8-12(9-11)10-13(14)15/h5,7-9H,2-4,6,10H2,1H3,(H,14,15)
InChi Key PEGQOIGYZLJMIB-UHFFFAOYSA-N
Canonical SMILES CCCCCc1cccc(c1)CC(=O)O
Isomeric SMILES CCCCCC1=CC(=CC=C1)CC(=O)O
PubChem CID 24749700
Molecular Weight 206.28

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Gagnon L, Leduc M, Thibodeau JF, Zhang MZ, Grouix B, Sarra-Bournet F, Gagnon W, Hince K, Tremblay M, Geerts L et al..  (2018)  A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84..  Am J Pathol,  188  (5): (1132-1148).  [PMID:29454750] [10.1021/op500134e]
2. Li Y, Chung S, Li Z, Overstreet JM, Gagnon L, Grouix B, Leduc M, Laurin P, Zhang MZ, Harris RC.  (2018)  Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control..  JCI Insight,  (10): (1755-70).  [PMID:29769449] [10.1021/op500134e]

Solution Calculators